J3380 — Vedolizumab 300 Mg Intravenous Solution
$18,989
All-payer median here
$16,813
Cash / self-pay here
5
payer/plan-name variants
Median over current-blob negotiated rates (COALESCE of standard / median / min–max midpoint, $0.01–$5M sentinel guard). Payers are canonical-grouped where a mapping exists; unmapped regional-plan name variants may appear as separate rows.